|
|
||||||||
J Thorac Cardiovasc Surg 2000;119:1169-1175
© 2000 The American Association for Thoracic Surgery
SURGERY FOR ACQUIRED CARDIOVASCULAR DISEASE |
From the Department of Cardiovascular Surgery, Hôpital Bichat; INSERM U-127, Hôpital Lariboisière; INSERM U-523 Institut de Myologie, Groupe Hospitalier Pitié-Salpétrière, and the Research in Imaging Laboratory, Faculté de Médecine Necker-Enfants Malades, Paris, France.
Address for reprints: Philippe Menasché, MD, Department of Cardiovascular Surgery, Hôpital Bichat, 46, rue Henri Huchard, 75018 Paris, France.
Objectives: Transplantation of fetal cardiomyocytes improves function of infarcted myocardium but raises availability, immunologic, and ethical issues that justify the investigation of alternate cell types, among which skeletal myoblasts are attractive candidates.
Methods: Myocardial infarction was created in rats by means of coronary artery ligation. One week later, the animals were reoperated on and intramyocardially injected with culture growth medium alone (controls, n = 15), fetal cardiomyocytes (5 x 106 cells, n = 11), or neonatal skeletal myoblasts (5 x 106 cells, n = 16). The injections consisted of a 150-µL volume and were made in the core of the infarct, and the animals were immunosuppressed. Left ventricular function was assessed by echocardiography immediately before transplantation and 1 month thereafter. Myoblast-transplanted hearts were then immunohistologically processed for the expression of skeletal musclespecific embryonic myosin heavy chain and cardiac-specific connexin 43.
Results: The left ventricular ejection fraction markedly increased in the fetal and myoblast groups from 39.3% ± 3.9% to 45% ± 3.4% (P = .086) and from 40.4% ± 3.6% to 47.3% ± 4.4% (P = .034), respectively, whereas it decreased in untreated animals from 40.6% ± 4% to 36.7% ± 2.7%. Transplanted myoblasts could be identified in all animals by the positive staining for skeletal muscle myosin. Conversely, clusters of connexin 43 were not observed on these skeletal muscle cells.
Conclusions: These results support the hypothesis that skeletal myoblasts are as effective as fetal cardiomyocytes for improving postinfarction left ventricular function. The clinical relevance of these findings is based on the possibility for skeletal myoblasts to be harvested from the patient himself.
This article has been cited by other articles:
![]() |
M. Khan, V. K. Kutala, D. S. Vikram, S. Wisel, S. M. Chacko, M. L. Kuppusamy, I. K. Mohan, J. L. Zweier, P. Kwiatkowski, and P. Kuppusamy Skeletal myoblasts transplanted in the ischemic myocardium enhance in situ oxygenation and recovery of contractile function Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2129 - H2139. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Baba, T. Heike, M. Yoshimoto, K. Umeda, H. Doi, T. Iwasa, X. Lin, S. Matsuoka, M. Komeda, and T. Nakahata Flk1+ cardiac stem/progenitor cells derived from embryonic stem cells improve cardiac function in a dilated cardiomyopathy mouse model Cardiovasc Res, October 1, 2007; 76(1): 119 - 131. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. K. Sim, L. Ye, and H. K. Haider New Strategy for Cardiac Repair: Genetically Modified Skeletal Myoblasts Asian Cardiovasc Thorac Ann, June 1, 2007; 15(3): 183 - 184. [Full Text] [PDF] |
||||
![]() |
S. Baba, T. Heike, K. Umeda, T. Iwasa, S. Kaichi, Y. Hiraumi, H. Doi, M. Yoshimoto, M. Kanatsu-Shinohara, T. Shinohara, et al. Generation of Cardiac and Endothelial Cells from Neonatal Mouse Testis-Derived Multipotent Germline Stem Cells Stem Cells, June 1, 2007; 25(6): 1375 - 1383. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Retuerto, J. T. Beckmann, J. Carbray, G. Patejunas, S. Sarateanu, B. J. Kane, B. Smulevitz, D. D. McPherson, and T. K. Rosengart Angiogenic pretreatment to enhance myocardial function after cellular cardiomyoplasty with skeletal myoblasts J. Thorac. Cardiovasc. Surg., February 1, 2007; 133(2): 478 - 484. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Siminiak, E. Meliga, O. Jerzykowska, and P. W. Serruys Percutaneous transplantation of skeletal myoblast in the treatment of post-infarction injury Eur. Heart J. Suppl., December 1, 2006; 8(suppl_H): H57 - H64. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Caspi and L. Gepstein Stem cells for myocardial repair Eur. Heart J. Suppl., September 1, 2006; 8(suppl_E): E43 - E54. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.C. Guarita-Souza, K.A.T. Carvalho, V. Woitowicz, C. Rebelatto, A. Senegaglia, P. Hansen, N. Miyague, J.C. Francisco, M. Olandoski, J.R. Faria-Neto, et al. Simultaneous Autologous Transplantation of Cocultured Mesenchymal Stem Cells and Skeletal Myoblasts Improves Ventricular Function in a Murine Model of Chagas Disease Circulation, July 4, 2006; 114(1_suppl): I-120 - I-124. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Murry, H. Reinecke, and L. M. Pabon Regeneration Gaps: Observations on Stem Cells and Cardiac Repair J. Am. Coll. Cardiol., May 2, 2006; 47(9): 1777 - 1785. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Murry, L. J. Field, and P. Menasche Cell-Based Cardiac Repair: Reflections at the 10-Year Point Circulation, November 15, 2005; 112(20): 3174 - 3183. [Full Text] [PDF] |
||||
![]() |
P. I. McConnell, C. L. del Rio, D. B. Jacoby, M. Pavlicova, P. Kwiatkowski, A. Zawadzka, J. H. Dinsmore, L. Astra, S. Wisel, and R. E. Michler Correlation of autologous skeletal myoblast survival with changes in left ventricular remodeling in dilated ischemic heart failure J. Thorac. Cardiovasc. Surg., October 1, 2005; 130(4): 1001 - 1001. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Azarnoush, A. Maurel, L. Sebbah, C. Carrion, A. Bissery, C. Mandet, J. Pouly, P. Bruneval, A. A. Hagege, and P. Menasche Enhancement of the functional benefits of skeletal myoblast transplantation by means of coadministration of hypoxia-inducible factor 1{alpha} J. Thorac. Cardiovasc. Surg., July 1, 2005; 130(1): 173 - 179. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Siminiak, D. Fiszer, O. Jerzykowska, B. Grygielska, N. Rozwadowska, P. Kalmucki, and M. Kurpisz Percutaneous trans-coronary-venous transplantation of autologous skeletal myoblasts in the treatment of post-infarction myocardial contractility impairment: the POZNAN trial Eur. Heart J., June 2, 2005; 26(12): 1188 - 1195. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Galli, A. Innocenzi, L. Staszewsky, L. Zanetta, M. Sampaolesi, A. Bai, E. Martinoli, E. Carlo, G. Balconi, F. Fiordaliso, et al. Mesoangioblasts, Vessel-Associated Multipotent Stem Cells, Repair the Infarcted Heart by Multiple Cellular Mechanisms: A Comparison With Bone Marrow Progenitors, Fibroblasts, and Endothelial Cells Arterioscler. Thromb. Vasc. Biol., April 1, 2005; 25(4): 692 - 697. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Schuh, S. Breuer, R. Al Dashti, N. Sulemanjee, P. Hanrath, C. Weber, B. F. Uretsky, and E. R. Schwarz Administration of Vascular Endothelial Growth Factor Adjunctive to Fetal Cardiomyocyte Transplantation and Improvement of Cardiac Function in the Rat Model Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 2005; 10(1): 55 - 66. [Abstract] [PDF] |
||||
![]() |
M. F. Pittenger and B. J. Martin Mesenchymal Stem Cells and Their Potential as Cardiac Therapeutics Circ. Res., July 9, 2004; 95(1): 9 - 20. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Askari, S. Unzek, C. K. Goldman, S. G. Ellis, J. D. Thomas, P. E. DiCorleto, E. J. Topol, and M. S. Penn Cellular, but not direct, adenoviral delivery of vascular endothelial growth factor results in improved left ventricular function and neovascularization in dilated ischemic cardiomyopathy J. Am. Coll. Cardiol., May 19, 2004; 43(10): 1908 - 1914. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.H. Grinnemo, A. Mansson, G. Dellgren, D. Klingberg, E. Wardell, V. Drvota, C. Tammik, J. Holgersson, O. Ringden, C. Sylven, et al. Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardium J. Thorac. Cardiovasc. Surg., May 1, 2004; 127(5): 1293 - 1300. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-F. Xiao, J.-Y. Min, and J. P. Morgan Immunosuppression and xenotransplantation of cells for cardiac repair Ann. Thorac. Surg., February 1, 2004; 77(2): 737 - 744. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-S. Li, H. Ito, K. Kajiwara, and K. Hamano Long-Term Survival of Xenografted Neonatal Cardiomyocytes by Adenovirus-Mediated CTLA4-Ig Expression and CD40 Blockade Circulation, October 7, 2003; 108(14): 1760 - 1765. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Thompson, S. M. Emani, B. H. Davis, E. J. van den Bos, Y. Morimoto, D. Craig, D. Glower, and D. A. Taylor Comparison of Intracardiac Cell Transplantation: Autologous Skeletal Myoblasts Versus Bone Marrow Cells Circulation, September 9, 2003; 108(90101): II-264 - 271. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Borenstein, P. Bruneval, M. Hekmati, C. Bovin;, L. Behr, C. Pinset, F. Laborde, and D. Montarras Noncultured, Autologous, Skeletal Muscle Cells Can Successfully Engraft Into Ovine Myocardium Circulation, June 24, 2003; 107(24): 3088 - 3092. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. H.L. Tang, P. W.M. Fedak, T. M. Yau, R. D. Weisel, A. Kulik, D. A.G. Mickle, and R.-K. Li Cell transplantation to improve ventricular function in the failing heart Eur. J. Cardiothorac. Surg., June 1, 2003; 23(6): 907 - 916. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Menasche Cell transplantation in myocardium Ann. Thorac. Surg., June 1, 2003; 75(90060): S20 - 28. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Dowell, M. Rubart, K. B.S. Pasumarthi, M. H. Soonpaa, and L. J. Field Myocyte and myogenic stem cell transplantation in the heart Cardiovasc Res, May 1, 2003; 58(2): 336 - 350. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Menasche Skeletal muscle satellite cell transplantation Cardiovasc Res, May 1, 2003; 58(2): 351 - 357. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Reffelmann and R. A. Kloner Cellular cardiomyoplasty--cardiomyocytes, skeletal myoblasts, or stem cells for regenerating myocardium and treatment of heart failure? Cardiovasc Res, May 1, 2003; 58(2): 358 - 368. [Full Text] [PDF] |
||||
![]() |
O. Agbulut, M.-L. Menot, Z. Li, F. Marotte, D. Paulin, A. A. Hagege, C. Chomienne, J.-L. Samuel, and P. Menasche Temporal patterns of bone marrow cell differentiation following transplantation in doxorubicin-induced cardiomyopathy Cardiovasc Res, May 1, 2003; 58(2): 451 - 459. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Menasche, A. A. Hagege, J.-T. Vilquin, M. Desnos, E. Abergel, B. Pouzet, A. Bel, S. Sarateanu, M. Scorsin, K. Schwartz, et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction J. Am. Coll. Cardiol., April 2, 2003; 41(7): 1078 - 1083. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Minami, H. Reinecke, and C. E. Murry Skeletal muscle meets cardiac muscle: Friends or foes? J. Am. Coll. Cardiol., April 2, 2003; 41(7): 1084 - 1086. [Full Text] [PDF] |
||||
![]() |
N. Al Attar, C. Carrion, S. Ghostine, I. Garcin, J.-T. Vilquin, A. A. Hagege, and P. Menasche Long-term (1 year) functional and histological results of autologous skeletal muscle cells transplantation in rat Cardiovasc Res, April 1, 2003; 58(1): 142 - 148. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Hassink, A. Brutel de la Riviere, C. L. Mummery, and P. A. Doevendans Transplantation of cells for cardiac repair J. Am. Coll. Cardiol., March 5, 2003; 41(5): 711 - 717. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. D. Pagani, H. DerSimonian, A. Zawadzka, K. Wetzel, A. S. B. Edge, D. B. Jacoby, J. H. Dinsmore, S. Wright, T. H. Aretz, H. J. Eisen, et al. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans: Histological analysis of cell survival and differentiation J. Am. Coll. Cardiol., March 5, 2003; 41(5): 879 - 888. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Weisel, R.-K. Li, D. A. G. Mickle, and T. M. Yau Cell transplantation comes of age J. Thorac. Cardiovasc. Surg., March 1, 2003; 125(90030): S53 - 54. [Full Text] [PDF] |
||||
![]() |
T. M. Yau, S. Tomita, R. D. Weisel, Z.-Q. Jia, L. C. Tumiati, D. A.G. Mickle, and R.-K. Li Beneficial effect of autologous cell transplantation on infarcted heart function: comparison between bone marrow stromal cells and heart cells Ann. Thorac. Surg., January 1, 2003; 75(1): 169 - 177. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ruel, R. A. Kelly, and F. W. Sellke Therapeutic Angiogenesis, Transmyocardial Laser Revascularization, and Cell Therapy Card. Surg. Adult, January 1, 2003; 2(2003): 715 - 750. [Full Text] |
||||
![]() |
L. Gepstein Derivation and Potential Applications of Human Embryonic Stem Cells Circ. Res., November 15, 2002; 91(10): 866 - 876. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. D. Cox, C. A. Thompson, and S. N. Oesterle Biointerventional cardiovascular therapy Eur. Heart J., November 2, 2002; 23(22): 1753 - 1756. [Full Text] [PDF] |
||||
![]() |
A. BEHFAR, L. V. ZINGMAN, D. M. HODGSON, J.-M. RAUZIER, G. C. KANE, A. TERZIC, and M. PUCEAT Stem cell differentiation requires a paracrine pathway in the heart FASEB J, October 1, 2002; 16(12): 1558 - 1566. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ghostine, C. Carrion, L. C. G. Souza, P. Richard, P. Bruneval, J.-T. Vilquin, B. Pouzet, K. Schwartz, P. Menasche, and A. A. Hagege Long-Term Efficacy of Myoblast Transplantation on Regional Structure and Function After Myocardial Infarction Circulation, September 24, 2002; 106(12_suppl_1): I-131 - I-136. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-H. Zimmermann, M. Didie, G. H. Wasmeier, U. Nixdorff, A. Hess, I. Melnychenko, O. Boy, W. L. Neuhuber, M. Weyand, and T. Eschenhagen Cardiac Grafting of Engineered Heart Tissue in Syngenic Rats Circulation, September 24, 2002; 106(12_suppl_1): I-151 - I-157. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sakakibara, K. Tambara, F. Lu, T. Nishina, G. Sakaguchi, N. Nagaya, K. Nishimura, R.-K. Li, R. D. Weisel, and M. Komeda Combined Procedure of Surgical Repair and Cell Transplantation for Left Ventricular Aneurysm: An Experimental Study Circulation, September 24, 2002; 106(12_suppl_1): I-193 - I-197. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sakakibara, K. Nishimura, K. Tambara, M. Yamamoto, F. Lu, Y. Tabata, and M. Komeda Prevascularization with gelatin microspheres containing basic fibroblast growth factor enhances the benefits of cardiomyocyte transplantation J. Thorac. Cardiovasc. Surg., July 1, 2002; 124(1): 50 - 56. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Shake, P. J. Gruber, W. A. Baumgartner, G. Senechal, J. Meyers, J. M. Redmond, M. F. Pittenger, and B. J. Martin Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects Ann. Thorac. Surg., June 1, 2002; 73(6): 1919 - 1926. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tomita, D. A. G. Mickle, R. D. Weisel, Z.-Q. Jia, L. C. Tumiati, Y. Allidina, P. Liu, and R.-K. Li Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation J. Thorac. Cardiovasc. Surg., June 1, 2002; 123(6): 1132 - 1140. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Roell, Z. J. Lu, W. Bloch, S. Siedner, K. Tiemann, Y. Xia, E. Stoecker, M. Fleischmann, H. Bohlen, R. Stehle, et al. Cellular Cardiomyoplasty Improves Survival After Myocardial Injury Circulation, May 21, 2002; 105(20): 2435 - 2441. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A Thompson and S. N Oesterle Biointerventional cardiology: the future interface of interventional cardiovascular medicine and bioengineering Vascular Medicine, May 1, 2002; 7(2): 135 - 140. [Abstract] [PDF] |
||||
![]() |
K. Suzuki, B. Murtuza, L. Heslop, J. E. Morgan, R. T. Smolenski, N. Suzuki, T. A. Partridge, and M. H. Yacoub Single fibers of skeletal muscle as a novel graft for cell transplantation to the heart J. Thorac. Cardiovasc. Surg., May 1, 2002; 123(5): 984 - 992. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Menasche and M Desnos Cardiac reparation: fixing the heart with cells, new vessels and genes Eur. Heart J. Suppl., April 1, 2002; 4(suppl_D): D73 - D81. [Abstract] [PDF] |
||||
![]() |
M. Takagaki, P. M. McCarthy, T. Tabata, R. Dessoffy, L. A. Cardon, J. Connor, Y. Ochiai, J. D. Thomas, G. S. Francis, J. B. Young, et al. Induction and maintenance of an experimental model of severe cardiomyopathy with a novel protocol of rapid ventricular pacing J. Thorac. Cardiovasc. Surg., March 1, 2002; 123(3): 544 - 549. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-H. Zimmermann, K. Schneiderbanger, P. Schubert, M. Didie, F. Munzel, J.F. Heubach, S. Kostin, W.L. Neuhuber, and T. Eschenhagen Tissue Engineering of a Differentiated Cardiac Muscle Construct Circ. Res., February 8, 2002; 90(2): 223 - 230. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.E. MURRY, M.L. WHITNEY, M.A. LAFLAMME, H. REINECKE, and L.J. FIELD Cellular Therapies for Myocardial Infarct Repair Cold Spring Harb Symp Quant Biol, January 1, 2002; 67(0): 519 - 526. [Abstract] [PDF] |
||||
![]() |
A. A. Hagege, J.-T. Vilquin, P. Bruneval, and P. Menasche Regeneration of the Myocardium: A New Role in the Treatment of Ischemic Heart Disease? Hypertension, December 1, 2001; 38(6): 1413 - 1415. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Suzuki, B. Murtuza, R. T. Smolenski, I. A. Sammut, N. Suzuki, Y. Kaneda, and M. H. Yacoub Cell Transplantation for the Treatment of Acute Myocardial Infarction Using Vascular Endothelial Growth Factor-Expressing Skeletal Myoblasts Circulation, September 18, 2001; 104(90001): I-207 - 212. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Suzuki, B. Murtuza, N. Suzuki, R. T. Smolenski, and M. H. Yacoub Intracoronary Infusion of Skeletal Myoblasts Improves Cardiac Function in Doxorubicin-Induced Heart Failure Circulation, September 18, 2001; 104(90001): I-213 - 217. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Yau, K. Fung, R. D. Weisel, T. Fujii, D. A.G. Mickle, and R.-K. Li Enhanced Myocardial Angiogenesis by Gene Transfer With Transplanted Cells Circulation, September 18, 2001; 104(90001): I-218 - 222. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Pouzet, S. Ghostine, J.-T. Vilquin, I. Garcin, M. Scorsin, A. A. Hagege, D. Duboc, K. Schwartz, and P. Menasche Is Skeletal Myoblast Transplantation Clinically Relevant in the Era of Angiotensin-Converting Enzyme Inhibitors? Circulation, September 18, 2001; 104(90001): I-223 - 228. [Abstract] [Full Text] [PDF] |
||||
|
|